Sign in

CIK 0001559053

  • Accelerated filer

PROTHENA CORP PUBLIC LTD CO

Sign in to watch
Ticker
PRTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Ireland
Entity type
Operating
Phone
+353 12362500
Business address
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
Former names
Prothena Corp plc, Neotope Corp Ltd
Open-market buys, last 90 days
$9,848,721
in 10 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. SCULLY WILLIAM P +$9.8M 10% owner 10 filings

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-12 Harfstrand Karl Anders Olof Director Returned to the company · Employee Stock Option (Right to Buy) −12,000 0
2021-02-12 Harfstrand Karl Anders Olof Director Grant or award · Employee Stock Option (Right to Buy) +6,315 6,315
2021-02-12 Walker Karin L Chief Accounting Officer Returned to the company · Employee Stock Option (Right to Buy) −17,500 0
2021-02-12 Walker Karin L Chief Accounting Officer Grant or award · Employee Stock Option (Right to Buy) +15,909 15,909
2021-02-12 Walker Karin L Chief Accounting Officer Returned to the company · Employee Stock Option (Right to Buy) −25,000 0
2021-02-12 Walker Karin L Chief Accounting Officer Grant or award · Employee Stock Option (Right to Buy) +15,625 15,625
2021-02-12 Walker Karin L Chief Accounting Officer Returned to the company · Employee Stock Option (Right to Buy) −30,000 0
2021-02-12 Walker Karin L Chief Accounting Officer Grant or award · Employee Stock Option (Right to Buy) +15,625 15,625
2021-02-12 Walker Karin L Chief Accounting Officer Returned to the company · Employee Stock Option (Right to Buy) −25,000 0
2021-02-12 Walker Karin L Chief Accounting Officer Grant or award · Employee Stock Option (Right to Buy) +18,796 18,796
2021-02-12 Kinney Gene G. President and CEO Returned to the company · Employee Stock Option (Right to Buy) −65,000 0
2021-02-12 Kinney Gene G. President and CEO Grant or award · Employee Stock Option (Right to Buy) +59,090 59,090
2021-02-12 Kinney Gene G. President and CEO Returned to the company · Employee Stock Option (Right to Buy) −65,000 0
2021-02-12 Kinney Gene G. President and CEO Grant or award · Employee Stock Option (Right to Buy) +40,625 40,625
2021-02-12 Kinney Gene G. President and CEO Returned to the company · Employee Stock Option (Right to Buy) −50,000 0
2021-02-12 Kinney Gene G. President and CEO Grant or award · Employee Stock Option (Right to Buy) +25,125 25,125
2021-02-12 Kinney Gene G. President and CEO Returned to the company · Employee Stock Option (Right to Buy) −30,000 0
2021-02-12 Kinney Gene G. President and CEO Grant or award · Employee Stock Option (Right to Buy) +16,759 16,759
2021-02-12 Kinney Gene G. President and CEO Returned to the company · Employee Stock Option (Right to Buy) −120,000 0
2021-02-12 Kinney Gene G. President and CEO Grant or award · Employee Stock Option (Right to Buy) +62,500 62,500

Page 38 of 41 · 819 trades